Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Fibrinogen antagonist from natrual source reported by Takeda

May 17, 1996

Argatroban enters phase III for HIT, HITTS

May 17, 1996

Active-site thrombin inhibitors reported by BMS

May 17, 1996

Teijin claims anticoagulant peptides

May 17, 1996

LY-329186 + aspirin effective in canine thrombosis model

May 10, 1996

Platelet antiaggregatory activity seen with Asahi's L-103

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

Nippon Steel discloses anticoagulant, antithrombotic peptide

May 10, 1996

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

PS-028: Fibrinogen antagonist from Taisho

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...